Saturday 16 January 2021
Home      All news      Contact us      RSS     
healtheuropa - 24 days ago

Long-acting injectable HIV treatment approved in Europe

The European Commission has approved marketing authorisation for the first long-acting injectable treatment for HIV to be made available in Europe. REKAMBYS, a rilpivirine injection developed by pharmaceutical company Janssen, is a prolonged-release suspension administered as an intramuscular injection. When rilpivirine is paired with injections of the integrase inhibitor cabotegravir, the combination of the two [ ] The post Long-acting injectable HIV treatment approved in Europe appeared first on Health Europa.


Latest News
Hashtags:   

acting

 | 

injectable

 | 

treatment

 | 

approved

 | 

Europe

 | 

Sources